IRIS PubliCatt

Chiusolo, Patrizia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.390
NA - Nord America 5.320
AS - Asia 1.090
AF - Africa 65
OC - Oceania 47
SA - Sud America 35
Continente sconosciuto - Info sul continente non disponibili 7
Totale 11.954
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.247
DE - Germania 1.968
SE - Svezia 1.011
CN - Cina 807
IT - Italia 650
UA - Ucraina 384
IE - Irlanda 332
FR - Francia 287
GB - Regno Unito 270
FI - Finlandia 121
PL - Polonia 116
IN - India 90
BE - Belgio 84
TR - Turchia 59
CI - Costa d'Avorio 55
CA - Canada 54
AU - Australia 46
BR - Brasile 24
IR - Iran 23
NL - Olanda 23
VN - Vietnam 19
AT - Austria 16
JP - Giappone 16
ES - Italia 14
MX - Messico 14
RU - Federazione Russa 14
RO - Romania 13
SG - Singapore 13
HU - Ungheria 12
ID - Indonesia 12
CH - Svizzera 8
NO - Norvegia 8
PT - Portogallo 8
HR - Croazia 7
GR - Grecia 6
HK - Hong Kong 6
IL - Israele 6
KR - Corea 6
CL - Cile 5
EE - Estonia 5
NP - Nepal 5
TH - Thailandia 5
BZ - Belize 4
DK - Danimarca 4
EU - Europa 4
MY - Malesia 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
EG - Egitto 3
MD - Moldavia 3
PE - Perù 3
RS - Serbia 3
SA - Arabia Saudita 3
BD - Bangladesh 2
BG - Bulgaria 2
CO - Colombia 2
IS - Islanda 2
LB - Libano 2
LI - Liechtenstein 2
SK - Slovacchia (Repubblica Slovacca) 2
AR - Argentina 1
GH - Ghana 1
IQ - Iraq 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MC - Monaco 1
MK - Macedonia 1
MT - Malta 1
NZ - Nuova Zelanda 1
PA - Panama 1
QA - Qatar 1
SC - Seychelles 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 11.954
Salva come PNG Salva come JPEG
Città #
Chandler 1.055
Dublin 327
Jacksonville 294
Ashburn 257
Dearborn 243
San Mateo 226
Nanjing 178
Ann Arbor 169
Wilmington 156
Houston 155
Beijing 136
Milan 133
Nürnberg 114
Woodbridge 114
Fairfield 113
Boston 109
Redwood City 105
Warsaw 105
Lancaster 91
Cattolica 89
Seattle 89
Nanchang 84
Brussels 82
Marseille 81
Princeton 80
Rome 78
Bremen 71
Lawrence 68
Los Angeles 56
Abidjan 55
Florence 51
Redmond 51
Izmir 49
Munich 47
Kunming 46
Boardman 36
Boydton 35
Tianjin 33
Helsinki 32
Norwalk 32
Cambridge 31
Chicago 31
Shanghai 30
Shenyang 30
Guangzhou 29
Leawood 28
Hangzhou 27
Changsha 26
Hefei 26
Mountain View 25
Zhengzhou 24
Hebei 23
Auburn Hills 22
Jiaxing 21
Washington 18
London 17
Hanoi 16
New York 16
Toronto 16
University Park 16
Augusta 15
San Francisco 14
Brooklyn 12
Changchun 10
Falls Church 10
Fremont 10
Lanzhou 10
Phoenix 10
Hermosillo 9
San Diego 9
Buffalo 8
Simi Valley 8
Canberra 7
Chengdu 7
Edinburgh 7
Fuzhou 7
Jinan 7
Vienna 7
Andover 6
Atlanta 6
Denver 6
Ottawa 6
Philadelphia 6
Sydney 6
Adelaide 5
Amsterdam 5
Caserta 5
Columbus 5
Costa Mesa 5
Menlo Park 5
Monmouth Junction 5
Mumbai 5
North Hollywood 5
San Jose 5
São Paulo 5
Tallinn 5
Ardabil 4
Belize City 4
Berlin 4
Bologna 4
Totale 6.076
Salva come PNG Salva come JPEG
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 1.075
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 343
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: An open-label, multicentre, randomised, phase 3 trial 300
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 278
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 219
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 158
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 145
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 136
Correlation between paraproteinaemia and viral reactivation after allo-SCT 128
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 127
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 126
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 126
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 125
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 125
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 123
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 123
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 118
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 116
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 116
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 114
Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy 112
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 110
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 110
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 108
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 107
Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia 107
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication 105
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia 104
Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms 100
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration 99
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 98
Role of 18F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients. 98
Prospective evaluation of epstein-barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 97
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 97
AB0 type does not affect platelet engraftment after autologous peripheral blood stem cell transplant in a series of 249 hematologic patients 96
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 96
Retrospective comparison of qualitative and quantitative reverse transcriptase polymerase chain reaction in diagnosing and monitoring the ALL1-AF4 fusion transcript in patients with acute lymphoblastic leukaemia. 93
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 93
Role of (18)F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients 92
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 91
Hyperleukocytosis and leukostasis: management of a medical emergency 91
Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms 90
Work related acute leukemia and mucor mycosis in a boat-builder 90
Hyperleukocytosis and leukostasis: management of a medical emergency 89
H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016 89
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 89
Allogeneic cord blood transfusions prevent fetal haemoglobin depletion in preterm neonates. Results of the CB-TrIP study 88
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 87
Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation 87
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 87
Neurologic improvement after peripheral blood stem cell transplantation in poems 85
Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease 85
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 85
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms 85
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 83
Non-tunnelled central venous catheters in adult stem cell transplantation recipients: an effective option 82
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population 80
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial 79
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 78
JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis 77
MTHFR polymorphisms involved in vitamin B12 deficiency associated with atrophic gastritis 77
Granulocyte transfusions as adjunctive treatment of invasive fungal diseases in neutropenic patients 76
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 76
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemia 74
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 74
Negative prognostic value of glutathione s-transferase (gstm1 and gstt1) deletions in adult acute myeloid leukemia. 72
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 72
UGT1A1 Polymorphism and Mortality Outcome after Allogeneic Stem Cell Transplantation with Busulfan Based Regimen 72
Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy 69
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 68
Allogeneic Hemopoietic Stem Cell Transplants in Patients with Acute Myeloid Leukemia (AML) Prepared with Busulfan and Fludarabine (BUFLU) or Thiotepa, Busulfan, and Fludarabine (TBF): A Retrospective Study 67
Fecal but not serum calprotectin is a potential marker of GVHD after stem cell transplantation. 66
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 66
Changes in protein serum levels during stem cell transplantation 65
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide :does graft cell content have an impact on main clinical outcomes? 62
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 62
Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) 61
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 60
Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo 58
Unrelated cord blood transplantation and post-transplant cyclophosphamide 58
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 58
Allogeneic hematopoietic stem cell transplantation in therapy-related myeloid neoplasms (t-MN) of the adult: Monocentric observational study and review of the literature 57
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 57
Mononuclear cell collection for extracorporeal photopheresis: Concentrate characteristics for off-line UV-A irradiation procedure 56
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 56
Inline and offline extracorporeal photopheresis: Device performance, cell yields and clinical response 56
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 56
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 54
Autologous peripheral blood stem cell transplantation and the role of lenalidomide in patients affected by poems syndrome 53
Unrelated cord blood transplantation and post-transplant cyclophosphamide 53
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 53
Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo 52
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 52
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 51
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 50
Allogeneic Transplant for Mycosis Fungoides in Patient with Wiskott-Aldrich Syndrome 50
Pre-Exposure to Defibrotide Prevents Endothelial Cell Activation by Lipopolysaccharide: An Ingenuity Pathway Analysis 50
The role of HLA-G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis. 49
Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors 49
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 49
Totale 10.256
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.200
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.200
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019932 0 0 0 0 209 131 174 73 66 70 126 83
2019/20202.111 319 175 173 147 203 236 199 96 122 166 156 119
2020/20211.250 81 116 81 96 111 101 114 32 150 60 264 44
2021/20221.539 147 91 43 69 103 39 35 218 89 126 260 319
2022/20233.278 434 431 243 474 226 375 196 248 322 120 147 62
2023/20241.050 90 496 130 178 156 0 0 0 0 0 0 0
Totale 12.227